American Association for Cancer Research

SHERPA: Unknown

People

  1. Solit
    Solit
  2. Ladanyi
    Ladanyi
  3. Rosen
    Rosen
  4. Hudis
    Hudis
  5. Scher
    Scher
  6. Baselga
    Baselga
  7. Berger
    Berger
  8. Norton
    Norton
  9. Reis-Filho
    Reis-Filho
  10. Cordon-Cardo
    Cordon-Cardo

Groups

  1. Department of Medicine (2134)
  2. Solid Tumor Oncology Division (1785)
  3. GSK Faculty (1633)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (779)
  6. Department of Pathology and Laboratory Medicine (721)
  7. Human Oncology and Pathogenesis Program (682)
  8. Surgery (644)
  9. Breast Medicine Service (610)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (581)
Search Within
Formats
  1. Journal Article (2033)
  2. Meeting Abstract (1999)
  3. Editorial (49)
  4. Review (29)
  5. Conference Paper (14)
  6. Correspondence (6)
  7. Miscellaneous (4)
  8. Guidelines (1)
Groups
  1. Department of Medicine (2134)
  2. Solid Tumor Oncology Division (1785)
  3. GSK Faculty (1633)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (779)
  6. Department of Pathology and Laboratory Medicine (721)

More Groups

People
  1. David Solit (175)
  2. Marc Ladanyi (157)
  3. Neal Rosen (142)
  4. Clifford Hudis (141)
  5. Howard Scher (139)
  6. Jose Baselga (138)

More People

Years
  1. 2025 (37)
  2. 2024 (75)
  3. 2023 (79)
  4. 2022 (266)
  5. 2021 (235)
  6. 2020 (272)

More Years

Publications
  1. Cancer Research (2703)
  2. Clinical Cancer Research (1432)

Results (4135)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Negative hyperselection of patients with HER2(+) and RAS wild-type metastatic colorectal cancer receiving dual HER2 blockade: The PRESSING-HER2 study
    Journal Article

    Randon, G.; Nakamura, Y.; Yaeger, R.; Lonardi, S.; Cremolini, C.; Elez, E.; Nichetti, F.; Ghelardi, F.; Nasca, V.; Bergamo, F.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Tumor volume growth rates and doubling times during active surveillance of IDH-mutant low-grade glioma
    Journal Article

    Bhatia, A.; Moreno, R.; Reiner, A. S.; Nandakumar, S.; Walch, H. S.; Thomas, T. M.; Nicklin, P. J.; Choi, Y.; Skakodub, A.; Malani, R.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Understanding genomic and social determinants of cancer immunotherapy outcome across ancestry
    Meeting Abstract

    Fong, C. J.; Waters, M.; Pichotta, K.; Jee, J.; Jutagir, D. R.; Ma, D.; Perea-Chamblee, T.; Kim, S.; Arora, K.; Mastrogiacomo, B.; more...
    Cancer Research (2023)

    Fulltext@MSK | Save
  • Analysis and visualization of longitudinal genomic and clinical data from the AACR Project GENIE Biopharma Collaborative in cBioPortal
    Journal Article

    de Bruijn, I.; Kundra, R.; Mastrogiacomo, B.; Tran, T. N.; Sikina, L.; Mazor, T.; Li, X.; Ochoa, A.; Zhao, G.; Lai, B.; more...
    Cancer Research (2023)

    Fulltext@MSK | Save
  • Clinical outcomes in NF2-mutated RCC treated with contemporary immunotherapy regimens
    Meeting Abstract

    Fitzgerald, K. N.; Duzgol, C.; Knezevic, A.; Jacobi, R.; Kotecha, R. R.; Aggen, D. H.; Carlo, M. I.; Shah, N. J.; Voss, M. H.; Feldman, D. R.; more...
    Cancer Research (2023)

    Fulltext@MSK | Save
  • Tumor immune microenvironment determinants of response to lenvatinib and a PD-1 blockade in clear cell renal cell carcinoma
    Meeting Abstract

    Vuong, L.; Kuo, F.; Jiang, H.; Mascareno, E. A.; Rappold, P.; Sabio, E.; Weiss, K.; Cornish, A.; Reese, S.; Adlesic, M.; more...
    Cancer Research (2023)

    Fulltext@MSK | Save
  • Randomized phase II trial of dendritic cell/myeloma fusion vaccine with lenalidomide maintenance after upfront autologous hematopoietic cell transplantation for multiple myeloma: BMT CTN 1401
    Journal Article

    Chung, D. J.; Shah, N.; Wu, J.; Logan, B.; Bisharat, L.; Callander, N.; Cheloni, G.; Anderson, K.; Chodon, T.; Dhakal, B.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Epigenetic cooperativity as a therapeutic vulnerability in cancer
    Editorial

    Kazansky, Y.; Kentsis, A.
    Cancer Research (2023)

    Fulltext@MSK | Save
  • Tipifarnib potentiates the antitumor effects of PI3Kα inhibition in PIK3CA- and HRAS-dysregulated HNSCC via convergent inhibition of mTOR activity
    Journal Article

    Smith, A. E.; Chan, S. C.; Wang, Z.; McCloskey, A.; Reilly, Q.; Wang, J. Z.; Patel, H. V.; Koshizuka, K.; Soifer, H. S.; Kessler, L.; more...
    Cancer Research (2023)

    Fulltext@MSK | Save
  • Assessing the genomic landscape of cervical cancers: Clinical opportunities and therapeutic targets
    Journal Article

    Friedman, C. F.; Ravichandran, V.; Miller, K.; Vanderbilt, C.; Zhou, Q.; Iasonos, A.; Vivek, M.; Mishra, P.; Leitao, M. M. Jr; Broach, V.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: